Targeting Interleukin-21 in Immune-Mediated Pathologies

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|11|5|645-649

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.5, 2010-05, pp. : 645-649

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting interleukin-21 in inflammatory diseases

By Sarra Massimiliano   Franzèè Eleonora   Pallone Francesco   Monteleone Giovanni  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 6, 2011-06 ,pp. : 695-702

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-21 in Immune and Allergic Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 4, 2012-08 ,pp. : 313-319

Bentham Science Publishers

Access to resources Recommend Favorite

Immune-mediated attenuation of HIV-1

By Chopera Denis R   Wright Jaclyn K   Brockman Mark A   Brumme Zabrina L  

Future Virology, Vol. 6, Iss. 8, 2011-08 ,pp. : 917-928

Future Medicine

Access to resources Recommend Favorite

Strategies for Novel Therapeutic Approaches Targeting Cytokines and Signaling Pathways of Osteoclasto- and Osteoblastogenesis in the Fight Against Immune-Mediated Bone and Joint Diseases

By  

Current Medicinal Chemistry, Vol. 15, Iss. 2, 2008-01 ,pp. : 127-136

Bentham Science Publishers

Access to resources Recommend Favorite

Piperacillin: Immune-mediated haemolytic crisis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1315, 2010-01 ,pp. : 40-40

Adis International

Access to resources Recommend Favorite